Beauty Farm Medical & Health Industry Inc

Beauty Farm Medical & Health Industry Inc maintains a strong liquidity position, with cash and equivalents amounting to CNY 1.63 billion, representing 32.4% of total assets. The company's liquidity FPT (free cash flow to total liabilities) is robust, with free cash flow of CNY 552.29 million and total liabilities of CNY 4.02 billion, resulting in a liquidity buffer of 13.7% of liabilities. The current ratio of 0.98 suggests a near-1:1 ratio of current assets to current liabilities, indicating a balanced short-term liquidity profile. Profitability metrics show a return on equity (ROE) of 31.07%, significantly above the median for the Personal Services industry, which typically ranges between 10% and 15%. The return on assets (ROA) of 6.29% is also above the industry median of 4% to 5%. The company's gross margin of 49.06% (CNY 1.47 billion gross profit on CNY 3.00 billion revenue) is in line with industry norms, but its operating margin of 15.32% (CNY 459.52 million operating income) is slightly below the median of 17% to 19%. The company's revenue is concentrated in a single business segment, as disclosed in its latest financials, with no geographic breakdown provided. This lack of geographic diversification may expose the company to regional economic or regulatory risks. The absence of segment-specific data limits the ability to assess the contribution of different product lines or services to overall performance. Growth trajectory is positive, with revenue of CNY 3.00 billion in the latest period. Analysts project a mean price target of CNY 35.29, implying a 79.6% upside from the current market price of CNY 19.46. The company's free cash flow of CNY 552.29 million and operating cash flow of CNY 999.09 million support its ability to fund operations and potentially reinvest in growth. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 1.27 is moderate for the industry, and the company's capital structure is supported by a strong cash position. However, the absence of detailed risk disclosures in recent filings limits the visibility into potential operational or strategic risks. Recent events include strong analyst sentiment, with a mean recommendation of 1.29 (favoring strong buy) and five strong-buy ratings. No recent filings or transcripts have been disclosed that would suggest material changes in the company's operations or strategy. The absence of recent events may indicate a stable but uneventful business environment.